Rachel Elizabeth Haurwitz (born May 20, 1985) is an American biochemist and structural biologist. She is the co-founder, chief executive officer, and president of Caribou Biosciences, a genome editing company.
Early life and education
Haurwitz was born on May 20, 1985. She grew up in Austin, Texas.[1] Her mother is an elementary school teacher and her father, an environmental journalist.[2]
Haurwitz began researching RNA during her undergraduate years.[3] She attended Harvard College where she earned an undergraduate degree. In 2007, she began doctoral studies at University of California, Berkeley. At the age of 21,[4] Haurwitz began working as a graduate student in Jennifer Doudna's laboratory, in 2008 where she completed her doctorate in molecular and cell biology.[5] Haurwitz originally intended on becoming an intellectual property lawyer for biotechnology patents but later chose to continue in science.[6]
Career
In 2011, Haurwitz and Doudna co-founded Caribou Biosciences, a gene editing spinout-startup company.[7] Haurwitz is the company's CEO and president. She holds several patents for CRISPR-based technologies.[5] The firm was initially housed in the basement of the building that housed Doudna's laboratory. The company supports the commercialization[8] of CRISPR technology in healthcare and agriculture.[9] Its researchers explore issues in antimicrobial resistance, food scarcity, and vaccine shortages.[9] The company licensed Berkeley's CRISPR patent and deals with agricultural and pharmaceutical companies and research firms.[10] In 2018, Haurwitz announced that the firm was shifting focus on medicine and developing cancer therapies targeting microbes.[2]
Personal life
She is a long-distance runner and is training for a marathon.[9] Haurwitz knits as a hobby.[6]
Recognition
In 2021, Haurwitz was selected as a Bloomberg New Economy Catalyst. As part of the program, she attended the annual New Economy Forum held in Singapore, and the Bloomberg New Economy Catalyst Retreat that same year.[11]
Selected works
Papers
External links
References
- Ellie Kincaid, Michela Tindera. Gene Hackers: The Young Biotech Entrepreneurs Looking To Make Billions By Editing Life Itself Forbes, May 14, 2019^
- Molly Fosco. This Scientist Turned CEO Wants to Gene-Edit a Way to Cure Cancer OZY, 2018-03-16, retrieved 2018-09-05^
- Elizabeth D. Herman. For biotech CEO Rachel Haurwitz, CRISPR is big business STAT, 2016-06-22, retrieved 2018-09-05^
- The two faces of Rachel Haurwitz MPNforum Magazine, 2015-04-09, retrieved 2018-09-05^
- Sarah Buhr. These two CRISPR experts are coming to Disrupt SF 2018 TechCrunch, 2018-09-04, retrieved 2018-09-05^
- 40 Under 40 Fortune, 2016-09-22, retrieved 2018-09-05^
- Rachel Haurwitz Forbes, retrieved 2018-09-05^
- Jack Leeming. How researchers are ensuring that their work has an impact Nature, 2018-04-05^
- NOMINEE: Rachel Haurwitz Newsweek, 2018-01-18, retrieved 2018-09-05^
- Antonio Regalado. One woman's ascent from lab rat to CEO of a CRISPR company MIT Technology Review, 2017, retrieved 2018-09-05^
- The Bloomberg New Economy Catalyst List Bloomberg.com, retrieved 2023-07-19^